Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Wegovy , which uses the same semaglutide molecule at higher weekly doses (up to 2.4 mg) and is approved by Health Canada specifically for chronic weight management, has no generic equivalent yet
Garca-Fernndez M, Castilla-Cortzar I, Daz-Snchez M, Dez Caballero F, Castilla A, Daz Casares A, Varela-Nieto I, Gonzlez-Barn S
The completed study demonstrated significant efficacy with 45% clinical response in the AJM300 group versus 21% in placebo (OR 3.30, 95% CI 1.73-6.29, p=0.00028), good tolerability with similar adverse event rates between groups, and established AJM300 as a potential novel induction therapy for moderately active UC
Designed for Life on GLP-1s
M.SchrackJ
Behav Brain Res (2017) 326:23743
